SUNNYVALE, Calif., Sept. 29 -- Cepheid (Nasdaq: CPHD) today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert(TM) MRSA/SA Skin and Soft Tissue Infection (SSTI) test, which runs on the GeneXpert(R) System, for the rapid detection of Methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus (SA, typically Methicillin-sensitive) [...]

National Cancer Institute Selects CambridgeSoft to Support Chemical Biology Consortium CAMBRIDGE, Mass.--The National Cancer Institute has selected the ChemBioOffice Enterprise suite as the single solution Informatics platform to support a highly collaborative drug discovery partnership, the Chemical Biology Consortium. The ChemBioOffice Enterprise suite will allow members of the Consortium to manage and share vital scientific [...]

Industry’s Most Cited Gene Expression Content Now Available in More Flexible, Affordable and Easier-to-Use Array Plate Formats SANTA CLARA, Calif.--Affymetrix Inc. (NASDAQ:AFFX) today announces the GeneTitan™ System, the only complete platform to automate customer workflow from target preparation through array processing and data analysis, which maximizes data reproducibility, user productivity and throughput scalability. The first [...]

Symyx Technologies, Inc. has announced the availability of Symyx Notebook - a new, enterprise electronic laboratory notebook (ELN) that is configurable to meet the needs of biologists and analytical chemists out-of-the-box. Symyx Notebook (https://www.symyx.com/downloads/Symyx%20Notebook%20Datasheet.pdf) simplifies laboratory operations and lowers costs by enabling R&D organisations to replace multiple discipline-specific ELNs with a single, multi-discipline application that [...]

Applied Biosystems Inc. (NYSE:ABI) today announced that the U.S. Food and Drug Administration has purchased seven of the company's 4000 QTRAP(R) Systems for the analysis of potential harmful pesticides in the U.S. food supply. These systems will be deployed at FDA field offices in Jefferson, Ark.; Irvine, Calif.; Lenexa, Kan.; Jamaica, NY; Bothell, Wash.; Atlanta, [...]

LEXINGTON, Mass., Sept. 29 -- RainDance Technologies announced today the launch of the dScreen Consortium, a research initiative conducted with sanofi-aventis, Paris (EURONEXT: SAN and NYSE: SNY), and Louis Pasteur University of Strasbourg, France, to develop the next generation of high-throughput screening (HTS) for drug discovery applications. The consortium was founded with the assistance of [...]

New Milton, UK, 29 September 2008 – Genetix Group plc (AIM: GTX) (“Genetix” or the “Company”), the cancer diagnostic and biopharmaceutical technologies group, today announces the appointment of Dr. Stephen Game as Head of Research and Development, a newly created position aimed at further strengthening the Company’s focus on innovation, with effect from 3rd November [...]

Tecan, a global leader in laboratory automation and detection, has been granted Transcreener® Far Red FP validated status for its high-end multimode readers Infinite® M1000, Infinite F500 and Safire2™, by BellBrookLabs, LLC, a R&D-driven company and provider of enabling drug discovery screening tools for the pharmaceutical industry. All of Tecan’s high-end multimode microplate readers outlined [...]

- Development of next generation of High-Throughput Screening to accelerate the drug discovery process - Paris, September 26, 2008 - Sanofi-aventis announced today the launch of the dScreen Consortium, a research initiative conducted with RainDance Technologies , Inc., Lexington, Massachusetts, and Louis Pasteur University, Strasbourg, France, to develop the next generation of High-Throughput Screening (HTS) [...]

Fluidigm Corporation today announced that due to the historic instability in the market, the company is withdrawing its registration statement for its initial public offering of shares of common stock. "We went out on September 5th with a very strong story and Fluidigm received a warm reception from the investment community. We explained how our [...]